MedTrace Logo

The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment

NCT03460106 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-02-11

No results posted yet for this study

Summary

Phase I: To develop and validate laboratory urine and blood test for the detection of medications commonly used in the treatment of asthma Phase II: to test the developed assay in the clinic, to determine its practicality to conduct, and its clinical utility in adherence assessment.

Conditions

Sponsors & Collaborators

  • Heart of England NHS Trust

    lead OTHER

Principal Investigators

  • Robert Mr Williams · Heart of England NHS Foundation Trust

  • Alexander Lawson Dr Lawson · Heart of England NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-03
Primary Completion
2020-09-30
Completion
2021-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03460106 on ClinicalTrials.gov